Artificial intelligence will replace the technology of stroke treatment in England

Stroke affects 85,000 people in England every year. Every minute saved in the initial assessment of people with stroke-like symptoms significantly increases the patient's chances of recovery. The country launched a state investment program in advanced artificial intelligence, thanks to which tens of thousands of stroke patients across the country will receive quick and high-quality treatment. Such results are possible due to increasing the accuracy of diagnosis and determining the optimal treatment of patients who have suffered a stroke. They also make it possible to optimize the time of doctors and staff.

A revolutionary stroke diagnosis program

The Brainomix e-Stroke system, which was developed in Great Britain, uses modern algorithms of artificial intelligence. The technology provides stroke specialists with remote access to images. Doctors receive real-time brain scan results, enabling more effective decision-making for stroke patients. Thus, more patients will be able to receive timely help.

The project is currently deployed in 11 stroke networks across the country, five of which were funded by the AI ​​in Health and Care Award. The additional funding enabled the detection of more than 4,500 large vessel occlusions (LVOs) in stroke patients. LVOs are one of the most time-sensitive diagnoses in medicine, and early diagnosis can lead to better patient outcomes.

The technology received funding in the first round of the government's AI in Health and Care Awards program. Its advantages were determined already at the early stage of application. The program makes it possible to shorten the time interval between the presenting with a stroke and treatment by more than 60 minutes. Therefore, with its help, it is possible to increase the effectiveness of treatment of stroke patients by 3 times, which gives an additional chance for rehabilitation without disability or with minor disability (possibility of functional independence in the ratio from 16 to 48%).

Health and Social Care Secretary Steve Barclay said:

"The development of artificial intelligence will make it possible to make more accurate diagnoses in a short period of time. The Brainomix company is an example of the practical use of the of artificial intelligence capabilities. The equipment saves time for determining one of the most sensitive diagnoses in medicine, and patients receive the necessary treatment much faster. I'm proud that the AI ​​Awards are giving researchers the opportunity to create revolutionary new technologies that will transform our healthcare system."

Riaz Rahman, Brainomix's Vice President of Global Healthcare, states that:

“The Brainomix e-Stroke platform has quickly become a cornerstone in stroke treatment. We have collected numerous cases that confirm the effectiveness of using e-Stroke. In some regions, it`s possible to see the tripling of post-operative patient functional scores after surgery and more than double the access to life-saving treatment with mechanical thrombectomy."

The £123 million AI Awards are run by the NIHR (National Institute for Health Research). The platform supports various technologies — from the initial stage of feasibility studies to the moment when they can be implemented at the national level.